Bacterial extracellular vesicles and their novel therapeutic applications in health and cancer.

bacterial extracellular vesicles cell cargo diagnosis host interactions infection microvesicles outer membrane vesicles therapy

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2022
Historique:
received: 14 06 2022
accepted: 20 10 2022
entrez: 28 11 2022
pubmed: 29 11 2022
medline: 30 11 2022
Statut: epublish

Résumé

Bacterial cells communicate with host cells and other bacteria through the release of membrane vesicles known as bacterial extracellular vesicles (BEV). BEV are established mediators of intracellular signaling, stress tolerance, horizontal gene transfer, immune stimulation and pathogenicity. Both Gram-positive and Gram-negative bacteria produce extracellular vesicles through different mechanisms based on cell structure. BEV contain and transfer different types of cargo such as nucleic acids, proteins and lipids, which are used to interact with and affect host cells such as cytotoxicity and immunomodulation. The role of these membranous microvesicles in host communication, intra- and inter-species cell interaction and signaling, and contribution to various diseases have been well demonstrated. Due to their structure, these vesicles can be easily engineered to be utilized for clinical application, as shown with its role in vaccine therapy, and could be used as a diagnostic and cancer drug delivery tool in the future. However, like other novel therapeutic approaches, further investigation and standardization is imperative for BEV to become a routine vector or a conventional treatment method.

Identifiants

pubmed: 36439225
doi: 10.3389/fcimb.2022.962216
pmc: PMC9691856
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

962216

Informations de copyright

Copyright © 2022 Hosseini-Giv, Basas, Hicks, El-Omar, El-Assaad and Hosseini-Beheshti.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cancers (Basel). 2019 Sep 06;11(9):
pubmed: 31500086
Infect Immun. 2009 Oct;77(10):4187-96
pubmed: 19651865
Science. 2014 Jan 10;343(6167):183-6
pubmed: 24408433
mSphere. 2021 Aug 25;6(4):e0052321
pubmed: 34232080
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19002-7
pubmed: 20956325
mBio. 2018 Jun 12;9(3):
pubmed: 29895636
Int J Mol Sci. 2019 Oct 25;20(21):
pubmed: 31731390
Annu Rev Microbiol. 2016 Sep 8;70:255-78
pubmed: 27359214
Front Microbiol. 2021 Mar 04;12:557902
pubmed: 33746909
J Extracell Vesicles. 2017 Jun 6;6(1):1324731
pubmed: 28717421
J Bacteriol. 2012 Jun;194(12):3241-9
pubmed: 22493021
Sci Rep. 2020 May 21;10(1):8467
pubmed: 32439871
Microb Pathog. 2017 Sep;110:1-6
pubmed: 28634130
Front Mol Biosci. 2021 Jan 13;7:566207
pubmed: 33521050
Cell. 2019 Aug 8;178(4):795-806.e12
pubmed: 31398337
Vaccine. 2012 Jan 20;30(5):825-9
pubmed: 22172507
Front Microbiol. 2015 Dec 16;6:1369
pubmed: 26733944
Mol Microbiol. 2007 Jan;63(2):545-58
pubmed: 17163978
PLoS Biol. 2020 Nov 3;18(11):e3000934
pubmed: 33141816
Environ Microbiol. 2014 Feb;16(2):598-610
pubmed: 23848955
J Extracell Vesicles. 2014 Aug 04;3:
pubmed: 25143819
Sci Rep. 2017 Sep 6;7(1):10724
pubmed: 28878270
mBio. 2016 Nov 1;7(6):
pubmed: 27803183
FEMS Microbiol Lett. 2018 Mar 1;365(5):
pubmed: 29390056
Crit Rev Microbiol. 2018 May;44(3):258-273
pubmed: 28741415
Clin Chem. 2008 Mar;54(3):482-90
pubmed: 18218722
J Biol Chem. 2019 Jan 25;294(4):1202-1217
pubmed: 30504226
PLoS Pathog. 2013;9(12):e1003797
pubmed: 24348251
Proteomics. 2019 Jan;19(1-2):e1800209
pubmed: 30488570
Asia Pac Allergy. 2020 Jul 08;10(3):e25
pubmed: 32789110
Biosci Microbiota Food Health. 2019;38(1):23-29
pubmed: 30705799
Exp Mol Med. 2018 Feb 23;50(2):e450
pubmed: 29472701
Semin Cell Dev Biol. 2015 Apr;40:97-104
pubmed: 25704309
PLoS Pathog. 2017 Nov 29;13(11):e1006760
pubmed: 29186191
Sci Rep. 2020 Feb 18;10(1):2860
pubmed: 32071370
Cell J. 2019 Apr;21(1):57-61
pubmed: 30507089
FASEB J. 2015 Feb;29(2):684-95
pubmed: 25392266
J Leukoc Biol. 2008 Aug;84(2):468-76
pubmed: 18511576
Antimicrob Agents Chemother. 2000 Dec;44(12):3249-56
pubmed: 11083623
Trends Microbiol. 2018 May;26(5):401-410
pubmed: 29548832
Oncogene. 2020 Nov;39(46):6951-6960
pubmed: 33060855
J Allergy Clin Immunol. 2016 Feb;137(2):507-516.e8
pubmed: 26433560
Nat Commun. 2019 Dec 11;10(1):5656
pubmed: 31827089
Sci Rep. 2017 Aug 18;7(1):8813
pubmed: 28821711
Infect Immun. 2020 Nov 16;88(12):
pubmed: 32989035
Appl Environ Microbiol. 2012 Sep;78(17):6217-24
pubmed: 22752175
J Proteome Res. 2014 May 2;13(5):2420-32
pubmed: 24620993
Front Microbiol. 2017 Apr 07;8:571
pubmed: 28439261
Exp Mol Med. 2017 May 12;49(5):e330
pubmed: 28496197
Biochim Biophys Acta. 2014 Aug;1843(8):1612-9
pubmed: 24370777
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28607018
PLoS One. 2015 Apr 21;10(4):e0123448
pubmed: 25897780
Am J Respir Cell Mol Biol. 2013 Oct;49(4):637-45
pubmed: 23713467
J Extracell Vesicles. 2021 Jul;10(9):e12120
pubmed: 34262675
Nat Commun. 2018 Apr 11;9(1):1379
pubmed: 29643357
J Antimicrob Chemother. 2017 Aug 1;72(8):2201-2207
pubmed: 28505330
Curr Opin Microbiol. 2018 Apr;42:1-6
pubmed: 28961452
Nat Commun. 2016 Jan 25;7:10515
pubmed: 26806181
Nat Rev Microbiol. 2015 Oct;13(10):620-30
pubmed: 26324094
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):E4790-7
pubmed: 24248369
Front Microbiol. 2017 Jul 11;8:1274
pubmed: 28744268
Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):372-393
pubmed: 28669749
Science. 2016 May 27;352(6289):1116-20
pubmed: 27230380
Microb Pathog. 2017 Mar;104:161-163
pubmed: 28111325
Cell Biochem Biophys. 2018 Jun;76(1-2):293-301
pubmed: 27796789
ACS Nano. 2014 Feb 25;8(2):1525-37
pubmed: 24410085
Adv Sci (Weinh). 2021 Feb 17;8(9):2004831
pubmed: 33977075
FEBS Lett. 2011 May 6;585(9):1357-62
pubmed: 21510946
J Dairy Sci. 2018 Oct;101(10):8662-8671
pubmed: 30100498
Proteomics. 2009 Dec;9(24):5425-36
pubmed: 19834908
Nat Commun. 2017 Sep 20;8(1):626
pubmed: 28931823
Front Mol Biosci. 2020 Sep 25;7:580913
pubmed: 33102527
Front Mol Biosci. 2020 Nov 24;7:596366
pubmed: 33330627
PLoS Pathog. 2016 Jun 13;12(6):e1005672
pubmed: 27295279
Sci Rep. 2017 Aug 1;7(1):7072
pubmed: 28765539
J Bacteriol. 2014 Jul;196(13):2355-66
pubmed: 24748612
Cell Mol Immunol. 2020 Apr;17(4):323-334
pubmed: 32203193
Microbiol Spectr. 2019 Jan;7(1):
pubmed: 30681067
Front Microbiol. 2020 Jan 14;10:3001
pubmed: 32010084
Exp Neurobiol. 2019 Apr;28(2):158-171
pubmed: 31138987
Appl Environ Microbiol. 2013 Mar;79(6):1874-81
pubmed: 23315742
BMC Microbiol. 2009 Oct 16;9:220
pubmed: 19835618
Nat Rev Microbiol. 2015 Oct;13(10):605-19
pubmed: 26373371
Nutrients. 2017 May 28;9(6):
pubmed: 28555037
Adv Drug Deliv Rev. 2021 Jun;173:125-140
pubmed: 33774113
Nutrients. 2019 May 09;11(5):
pubmed: 31075872
mBio. 2019 Oct 8;10(5):
pubmed: 31594810
Emerg Microbes Infect. 2019;8(1):808-822
pubmed: 31164053
Curr Genet. 2016 Feb;62(1):71-9
pubmed: 26328805
Front Microbiol. 2020 Mar 24;11:432
pubmed: 32265873
Adv Mater. 2020 Nov;32(47):e2002085
pubmed: 33015871
Acta Pharm Sin B. 2020 Aug;10(8):1534-1548
pubmed: 32963948
Gut Microbes. 2018 Jan 2;9(1):1-12
pubmed: 28686482
Clin Proteomics. 2016 Mar 09;13:6
pubmed: 26962304
Front Microbiol. 2022 Feb 23;13:835058
pubmed: 35283837
PLoS Pathog. 2009 Apr;5(4):e1000382
pubmed: 19360133
J Bacteriol. 1989 May;171(5):2499-505
pubmed: 2496108
Nat Commun. 2017 Sep 7;8(1):481
pubmed: 28883390
Proteomics. 2019 Jan;19(1-2):e1800170
pubmed: 30358122
J Bacteriol. 2013 Jul;195(13):2971-81
pubmed: 23625841
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Nat Rev Microbiol. 2019 Jan;17(1):13-24
pubmed: 30397270
PLoS One. 2015 Jan 12;10(1):e0116896
pubmed: 25581302
Mol Microbiol. 2009 Jun;72(6):1395-407
pubmed: 19432795
Mol Microbiol. 2014 Jul;93(1):183-98
pubmed: 24826903
Nat Protoc. 2020 Jan;15(1):40-67
pubmed: 31776460
Front Cell Infect Microbiol. 2017 May 03;7:154
pubmed: 28516064
Nat Commun. 2012;3:1073
pubmed: 23011127
Proteomics Clin Appl. 2017 Jan;11(1-2):
pubmed: 27594576
Appl Microbiol Biotechnol. 2016 May;100(9):3887-92
pubmed: 27020292
Int J Mol Sci. 2016 Mar 22;17(3):423
pubmed: 27011175
Sci Rep. 2015 Aug 18;5:13252
pubmed: 26283502
Front Microbiol. 2020 Dec 09;11:600221
pubmed: 33362747
mBio. 2014 May 20;5(3):e00979-14
pubmed: 24846379
FEMS Microbiol Lett. 2009 Sep;298(1):1-11
pubmed: 19519769
Appl Environ Microbiol. 1999 Aug;65(8):3633-40
pubmed: 10427060
Front Microbiol. 2017 Jun 09;8:1053
pubmed: 28649237
J Antimicrob Chemother. 2007 Feb;59(2):184-90
pubmed: 17114173
PLoS One. 2013 Oct 24;8(10):e76520
pubmed: 24204633
Transl Clin Pharmacol. 2018 Sep;26(3):103-110
pubmed: 32055558
J Bacteriol. 2013 Sep;195(18):4161-73
pubmed: 23852867
J Antimicrob Chemother. 2000 Jan;45(1):9-13
pubmed: 10629007
mBio. 2018 Nov 20;9(6):
pubmed: 30459192
Sci Adv. 2020 Jul 03;6(27):eaba2735
pubmed: 32923586
Front Microbiol. 2020 Jan 17;10:3026
pubmed: 32038523
Front Microbiol. 2021 Mar 11;12:634226
pubmed: 33776967
Sci Rep. 2015 Oct 20;5:15329
pubmed: 26483327
Cell. 2014 Mar 27;157(1):77-94
pubmed: 24679528
Front Microbiol. 2021 Oct 08;12:713669
pubmed: 34690958
Front Microbiol. 2018 Aug 30;9:2015
pubmed: 30214435
PLoS Pathog. 2016 Sep 01;12(9):e1005816
pubmed: 27583406
J Bacteriol. 1993 Sep;175(18):5798-805
pubmed: 8376327
Res Microbiol. 2003 Nov;154(9):637-43
pubmed: 14596901
Sci Rep. 2020 Dec 3;10(1):21066
pubmed: 33273518
FEMS Microbiol Lett. 2018 Jul 1;365(13):
pubmed: 29846577
Proteomics. 2011 Aug;11(16):3424-9
pubmed: 21751344
Medicine (Baltimore). 2021 May 7;100(18):e25835
pubmed: 33950995
J Bacteriol. 2013 Jan;195(2):213-9
pubmed: 23123904
J Dent Res. 2017 Apr;96(4):458-466
pubmed: 28068479
Microbiol Immunol. 2004;48(12):965-9
pubmed: 15611613
J Nutr. 2016 Nov;146(11):2206-2215
pubmed: 27708120
Microbes Infect. 2014 Jan;16(1):6-16
pubmed: 24140554
Exp Mol Med. 2020 Mar;52(3):338-347
pubmed: 32203101
Front Immunol. 2012 May 08;3:107
pubmed: 22586430
J Clin Invest. 2011 Apr;121(4):1471-83
pubmed: 21364279
Front Microbiol. 2017 Jun 13;8:1040
pubmed: 28659878
Mol Microbiol. 2006 Feb;59(4):1114-28
pubmed: 16430688
Nat Commun. 2016 Apr 14;7:11220
pubmed: 27075392
Appl Environ Microbiol. 2014 Jun;80(11):3469-83
pubmed: 24657872
J Allergy Clin Immunol. 2005 Jun;115(6):1260-7
pubmed: 15940144
PLoS One. 2013 Aug 20;8(8):e73196
pubmed: 23977379

Auteurs

Niloufar Hosseini-Giv (N)

Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.

Alyza Basas (A)

UNSW Microbiome Research Centre, St George and Sutherland Clinical Campuses, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.

Chloe Hicks (C)

UNSW Microbiome Research Centre, St George and Sutherland Clinical Campuses, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.

Emad El-Omar (E)

UNSW Microbiome Research Centre, St George and Sutherland Clinical Campuses, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.

Fatima El-Assaad (F)

UNSW Microbiome Research Centre, St George and Sutherland Clinical Campuses, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.

Elham Hosseini-Beheshti (E)

School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
The Sydney Nano Institute, The University of Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH